FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

385055001: Tablet (basic dose form)

  • SNOMED CT Concept\Qualifier value\Basic dose form (basic dose form)\Solid dose form\A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition.

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1479317011 Tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3534602016 Tablet (basic dose form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3635452013 A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. en Definition Active Entire term case sensitive (core metadata concept) SNOMED CT core
1459233010 Tablet (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1479317011 Tablet en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1479317011 Tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2536656014 Tablets en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2536656014 Tablets en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2613089014 Tablet dose form (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2660323018 Tablet dose form (qualifier value) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2660323018 Tablet dose form (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2770896013 Tablet dose form en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2770896013 Tablet dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3534602016 Tablet (basic dose form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3635452013 A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. en Definition Active Entire term case sensitive (core metadata concept) SNOMED CT core
13111000188116 comprimé fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
13111000188116 comprimé fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

3 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Is a Type of drug preparation false Inferred relationship Existential restriction modifier (core metadata concept)
A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Is a Oral dose form false Inferred relationship Existential restriction modifier (core metadata concept)
A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Is a Solid dose form true Inferred relationship Existential restriction modifier (core metadata concept)
A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Has state of matter (attribute) Solid (state of matter) true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Moracizine 200 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely moracizine 250 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely moracizine 300 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely propranolol hydrochloride 10 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely propranolol hydrochloride 40 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Propranolol hydrochloride 80 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Propranolol hydrochloride 160 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely acebutolol 400 milligram/1 each conventional release oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely atenolol 50 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Atenolol 100 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely atenolol 25 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Betaxolol hydrochloride 20 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Labetalol hydrochloride 100 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely labetalol hydrochloride 200 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely labetalol hydrochloride 400 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Labetalol hydrochloride 50 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Metoprolol tartrate 100 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Metoprolol tartrate 50 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Metoprolol tartrate 200mg m/r tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Nadolol 40 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Nadolol 80 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Oxprenolol hydrochloride 20mg tablet (substance) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Oxprenolol hydrochloride 40 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely oxprenolol hydrochloride 80 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely oxprenolol hydrochloride 160 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Oxprenolol hydrochloride 160mg m/r tablet (substance) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Pindolol 5 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Pindolol 15 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Sotalol hydrochloride 40 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely sotalol hydrochloride 80 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Sotalol hydrochloride 200 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Sotalol hydrochloride 160 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely timolol maleate 10 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Hydrochlorothiazide 12.5 mg and metoprolol tartrate 100 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Metoprolol tartrate+hydrochlorothiazide 200mg/25mg m/r tablet (substance) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Bendroflumethiazide 5 mg and nadolol 40 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Bendroflumethiazide 5 mg and nadolol 80 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely clopamide 5 milligram and pindolol 10 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely amiloride hydrochloride 2.5 milligram and hydrochlorothiazide 25 milligram and timolol maleate 10 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Bendroflumethiazide 2.5 mg and timolol maleate 10 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Atenolol 50 mg and chlortalidone 12.5 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Co-tenidone 100mg/25mg tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Co-prenozide 160mg/0.25mg m/r tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely acebutolol 200 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Bisoprolol fumarate 5 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Bisoprolol fumarate 10 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely bisoprolol 10 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Bisoprolol fumarate 1.25 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Bisoprolol fumarate 2.5 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Bisoprolol fumarate 3.75 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely bisoprolol fumarate 7.5 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Celiprolol hydrochloride 200 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely celiprolol hydrochloride 400 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Carvedilol 12.5 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Carvedilol 25 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Carvedilol 3.125 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Carvedilol 6.25mg tablet (substance) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Nebivolol 5mg tablet (substance) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Hydralazine hydrochloride 25 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Hydralazine hydrochloride 50 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Minoxidil 2.5 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Minoxidil 5 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Minoxidil 10 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Clonidine hydrochloride 100 microgram oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Clonidine hydrochloride 300micrograms tablet (substance) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Methyldopa 125 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Methyldopa 250 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Methyldopa 500 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Moxonidine 200 microgram oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely moxonidine 400 microgram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely betanidine 10 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely debrisoquine 10 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely indoramin 20 milligram/1 each conventional release oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Indoramin 25mg tablet (substance) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Prazosin hydrochloride 500micrograms + 1mg tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely prazosin (as prazosin hydrochloride) 500 microgram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely prazosin (as prazosin hydrochloride) 1 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Prazosin (as prazosin hydrochloride) 2 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Prazosin hydrochloride 5mg tablet (substance) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Terazosin (as terazosin hydrochloride) 5 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Terazosin (as terazosin hydrochloride) 10 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Terazosin 1mg+2mg tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Terazosin (as terazosin hydrochloride) 2 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely doxazosin (as doxazosin mesilate) 1 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Doxazosin (as doxazosin mesilate) 2 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely doxazosin (as doxazosin mesilate) 4 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Captopril 25 mg and hydrochlorothiazide 12.5 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Captopril 50 mg and hydrochlorothiazide 25 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely captopril 12.5 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Captopril 25 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Captopril 50 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Enalapril maleate+hydrochlorothiazide 20mg/12.5mg tablet (substance) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely enalapril maleate 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Enalapril maleate 5 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely enalapril maleate 10 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Enalapril maleate 20 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely lisinopril 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely lisinopril 5 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Lisinopril 10 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Lisinopril 20 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 20 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)

Start Previous Page 3 of 28 Next End

This concept is not in any reference sets

Back to Start